Showing results (281-290 of 392) with videos related to

Sort By:
Pageof 40
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 1999
IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesisM P Keane, J A Belperio, D A Arenberg, et al.
American Journal of Respiratory and Critical Care Medicine|October 27, 2004
CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodelingMarie D Burdick, Lynne A Murray, Michael P Keane, et al.
Chest|February 27, 2025
Deciphering the Role of Fluorodeoxyglucose-Positron Emission Tomography/CT Imaging in the Management of SarcoidosisRyan Donnelly, Alessandro N Franciosi, Sarah H Forde, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|April 25, 2012
Early and late preterm delivery rates - a comparison of differing tocolytic policies in a single urban populationMark P Hehir, Hugh D O'Connor, Etaoin M Kent, et al.
The American Journal of Cardiology|August 1, 1990
Long follow-up (to 43 years) of ventricular septal defect with audible aortic regurgitationL A Rhodes, J F Keane, J P Keane, et al.
Journal of Leukocyte Biology|July 29, 2000
CXC chemokines in angiogenesisJ A Belperio, M P Keane, D A Arenberg, et al.
ILAR Journal|June 15, 2001
Use of Immunodeficient Mice for the Evaluation of CXC Chemokines in the Regulation of Tumor-associated AngiogenesisRobert M. Strieter, Christina L. Addison, Jan E. Ehlert, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1993
Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonistM Poncelet, M Arnone, M Heaulme, et al.
Respiratory Care|November 13, 2014
Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokersPatrick D Mitchell, Jeeban P Das, David J Murphy, et al.
The Journal of Biological Chemistry|April 2, 2005
Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alphaRoderick J Phillips, Javier Mestas, Mehrnaz Gharaee-Kermani, et al.
Pageof 40